StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials cash

Cash and short-term investments held at the end of each period.

Regentis Biomaterials's cash was $7.38M at Dec 31, 2025. For fiscal 2025 it was $7.38M.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.38M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$7.38M–

More Regentis Biomaterials figures

See a number that looks wrong?